Cite
A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer's disease in outpatients treated with donepezil.
MLA
Finkel, Sanford I., et al. “A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Sertraline in the Treatment of the Behavioral Manifestations of Alzheimer’s Disease in Outpatients Treated with Donepezil.” International Journal of Geriatric Psychiatry, vol. 19, no. 1, Jan. 2004, pp. 9–18. EBSCOhost, https://doi.org/10.1002/gps.998.
APA
Finkel, S. I., Mintzer, J. E., Dysken, M., Krishnan, K. R. R., Burt, T., & McRae, T. (2004). A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer’s disease in outpatients treated with donepezil. International Journal of Geriatric Psychiatry, 19(1), 9–18. https://doi.org/10.1002/gps.998
Chicago
Finkel, Sanford I., Jacobo E. Mintzer, Maurice Dysken, K. R. R. Krishnan, Tal Burt, and Thomas McRae. 2004. “A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Sertraline in the Treatment of the Behavioral Manifestations of Alzheimer’s Disease in Outpatients Treated with Donepezil.” International Journal of Geriatric Psychiatry 19 (1): 9–18. doi:10.1002/gps.998.